Abiopharma

🔍 Lund Deanna H (Director)

Company: KRATOS DEFENSE & SECURITY SOLUTIONS, INC. (KTOS)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Sold 2,300 shares of Common Stock at $61.6277 per share (Direct)
  Date: 2026-05-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 297,900.00 | transaction_form_type: 4 | Footnotes: F1, F2, F4
• Sold 2,700 shares of Common Stock at $62.4945 per share (Direct)
  Date: 2026-05-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 295,200.00 | transaction_form_type: 4 | Footnotes: F1, F3, F4

Footnotes:

• F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on May 20, 2025.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.12 to $62.11 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.12 to $62.85 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
• F4: Includes 16,626 shares purchased through Issuer's Employee Stock Purchase Plan and approximately 20,274 shares held through Issuer's 401(k) Plan.